Literature DB >> 14678133

Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia.

Luigi Padeletti1, Helmut Pürerfellner, Stuart W Adler, Theodore J Waller, Mark Harvey, Lewis Horvitz, Reece Holbrook, Kitty Kempen, Andrew Mugglin, Douglas A Hettrick.   

Abstract

INTRODUCTION: The combined role of atrial septal lead location and atrial pacing algorithms in the prevention of atrial tachyarrhythmias (AT/AF), including both atrial fibrillation and flutter, is unknown. We tested the hypothesis that atrial prevention pacing algorithms could decrease AT/AF frequency in patients with atrial septal leads, bradycardia, and paroxysmal AT/AF. METHODS AND
RESULTS: A total of 298 patients (age 70 +/- 10 years; 61% male) from 35 centers were implanted with a DDDRP pacing system including three AT/AF prevention pacing algorithms. Lead site was randomized at implant to right atrial septal or nonseptal. Patients were randomized 1 month postimplant to AT/AF prevention ON or OFF for 3 months and then crossed over for 3 months. Patients logged symptomatic AT/AF episodes via a manual activator. Prevention efficacy was evaluated based on intention-to-treat in 277 patients (138 septal) with complete follow-up. No changes in device-recorded AT/AF frequency or burden were observed with algorithms OFF versus ON or between patients randomized to septal versus nonseptal lead location. Analysis of other secondary outcomes revealed that AT/AF prevention pacing resulted in decreased atrial premature contractions in both the septal (1.9 [0.2-8.7] vs 3.3 [0.3-10.6]x 103/day; P < 0.01) and nonseptal groups (0.9 [0.2-3.3] vs 1.3 [0.3-5.5]x 103/day; P < 0.001). Patients with septal leads had fewer symptomatic AT/AF episodes ON versus OFF (1.4 +/- 3.0 vs 2.5 +/- 5.2/month, P = 0.01).
CONCLUSION: The combination of three atrial prevention pacing algorithms did not decrease device classified atrial tachyarrhythmia frequency or burden during a 3-month cross-over period in bradycardic patients and septal or nonseptal atrial pacing leads. Prevention pacing was associated with decreased frequency of premature atrial contractions and with decreased symptomatic atrial tachyarrhythmia frequency in patients with atrial septal leads.

Entities:  

Mesh:

Year:  2003        PMID: 14678133     DOI: 10.1046/j.1540-8167.2003.03191.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  30 in total

Review 1.  [Cardiac resynchronization therapy and arrhythmias].

Authors:  D Böcker; R Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2005-03

2.  Future easy and physiological cardiac pacing.

Authors:  Eraldo Occhetta; Miriam Bortnik; Paolo Marino
Journal:  World J Cardiol       Date:  2011-01-26

3.  Atrial pacing for rhythm control of atrial fibrillation.

Authors:  I C van Gelder; A C P Wiesfeld
Journal:  Neth Heart J       Date:  2008-06       Impact factor: 2.380

4.  Clinical application of pacemakers in atrial tachyarrhythmias.

Authors:  W G de Voogt; N M van Hemel
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

Review 5.  Atrial fibrillation: profit from cardiac pacing?

Authors:  A Yang; B Lüderitz; T Lewalter
Journal:  Z Kardiol       Date:  2005-03

Review 6.  Atrial fibrillation and conduction system disease: the roles of catheter ablation and permanent pacing.

Authors:  Anand Thiyagarajah; Dennis H Lau; Prashanthan Sanders
Journal:  J Interv Card Electrophysiol       Date:  2018-08-03       Impact factor: 1.900

Review 7.  Controversies in pacing: indications and programming.

Authors:  Anne M Gillis; Rik Willems
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

8.  Diagnostic tools for atrial tachyarrhythmias in implantable pacemakers: a review of technical options and pitfalls.

Authors:  W G de Voogt; N M van Hemel
Journal:  Neth Heart J       Date:  2008-06       Impact factor: 2.380

9.  The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.

Authors:  Rick A Veasey; Anita Arya; Nick Freemantle; John Silberbauer; Nikhil R Patel; Guy W Lloyd; A Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2010-01-16       Impact factor: 1.900

10.  Effect of atrial tachyarrhythmia duration on percentage of time with atrial pacing in pacemaker patients with paroxysmal atrial fibrillation.

Authors:  Andreas Schuchert; Gaby Frost; Thomas Meinertz
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.